Oncology & Cancer
How deadly brain cancer evades treatments
McMaster University researcher Sheila Singh and her team have discovered how glioblastoma, a lethal brain cancer, can evade treatments and kill.
Sep 29, 2022
0
69
News tagged with glioblastoma patients
Medical research
Experimental brain cancer drug fast tracked in clinical trials
An experimental drug being trialed for advanced solid tumors, including the most aggressive brain cancer—glioblastoma—has passed the first phase with flying colors, raising hopes for an effective new treatment.
Sep 23, 2022
0
5
Medical research
Research reveals potential targets for therapeutic development for glioblastoma
The University of Alabama at Birmingham Marnix E. Heersink School of Medicine's Department of Radiation Oncology researchers have identified potential targets to help overcome therapy-resistant tumors in patients with glioblastoma, ...
Sep 21, 2022
0
16
Medications
Drug combination that might prove effective for one in three glioblastoma patients
Based on the findings of a new study led by the Translational Genomics Research Institute (TGen), part of City of Hope, a coast-to-coast clinical trial is planned that, if successful, could lead to FDA approval of the first ...
May 3, 2022
0
70
Oncology & Cancer
Using electricity to treat cancer
Electricity has formed the basis of many aspects of the modern world, from providing reliable sources of light to powering home appliances and computers. Now, researchers are studying how electricity can be harnessed as a ...
Apr 12, 2022
0
14
Oncology & Cancer
Glioblastoma in older adults: Improving survival and quality of life
Glioblastoma is an aggressive cancer that can occur in the brain or spinal cord. It can occur at any age, but glioblastoma is more common in older adults. The average age of diagnosis is 64.
Mar 8, 2022
0
10
Oncology & Cancer
Which glioblastoma patients will respond to immunotherapy? A biomarker may hold answers
Northwestern Medicine scientists have discovered a new biomarker to identify which patients with brain tumors called glioblastomas—the most common and malignant of primary brain tumors—might benefit from immunotherapy.
Nov 29, 2021
0
73
Oncology & Cancer
Neuroinflammation protein linked to worse survival in men with glioblastoma
Scientists have discovered a new link that could bring the scientific and medical community closer to understanding why glioblastoma, the most common malignant brain tumor, is deadlier in males than females.
Oct 18, 2021
0
20
Oncology & Cancer
Looking at tumors through a new lens
Neoadjuvant immune checkpoint blockade (ICB) is a promising treatment for melanoma and other cancer types, and has recently been shown to provide a modest survival benefit for patients with recurrent glioblastoma. To improve ...
Jun 29, 2021
0
13
Oncology & Cancer
Microglia, Stockholm syndrome and miraculous cures in glioblastoma patients
Despite access to some of the best possible medical care in the world, Senators John McCain and Edward Kennedy both died within 18 months of their diagnosis of glioblastoma, an aggressive form of brain cancer. While this ...
Apr 19, 2021
0
190
